Immunology and Autoimmunity Testing
Immunology and autoimmunity testing is the branch of clinical laboratory science that measures components and products of the immune system to support the diagnosis and monitoring of autoimmune, immunodeficiency, allergic, inflammatory, and neoplastic conditions. It spans the detection of autoantibodies, the quantification of immunoglobulins and complement proteins, the assessment of immune cell number and function, and the measurement of tumor-associated markers.
Definition
Immunologic testing comprises laboratory procedures that detect and quantify antibodies, antigens, complement components, immune cells, and related analytes to characterise the state and reactivity of a patient's immune system.
Scope
This area orients the reader to the major families of immunologic laboratory tests and the analytic principles behind them. It covers autoantibody detection, complement assessment, immunoglobulin and serum protein analysis, immunodeficiency and immune-status testing, and tumor-associated serology. It treats these as methodological and reference topics within clinical laboratory science rather than as clinical decision rules.
Sub-topics
Core questions
- Which immune analyte should be measured to address a given clinical question, and by what assay principle?
- How are immunoassays standardised, calibrated, and interpreted against reference intervals?
- How do autoantibody, complement, immunoglobulin, and cellular tests complement one another in characterising immune dysfunction?
Key concepts
- Antigen-antibody binding and assay specificity
- Immunoassay formats (ELISA, immunofluorescence, nephelometry, flow cytometry)
- Autoantibodies as markers of self-reactivity
- Complement activation and consumption
- Polyclonal versus monoclonal immunoglobulin patterns
- Sensitivity, specificity, and predictive value of immunologic markers
Mechanisms
Most immunologic tests exploit the specific, high-affinity binding between an antibody and its antigen. Solid-phase immunoassays (such as ELISA), indirect immunofluorescence, and turbidimetric or nephelometric methods translate that binding into a measurable signal, while flow cytometry enumerates and phenotypes immune cells by labelled surface markers. Autoantibody assays detect antibodies directed against self-antigens; complement assays measure the proteins of the cascade or their functional activity; protein electrophoresis and immunofixation resolve immunoglobulin patterns. Interpretation depends on assay calibration, defined reference intervals, and the pre-test probability of the condition being evaluated.
Clinical relevance
Immunologic tests provide objective evidence used in classifying autoimmune diseases, recognising immunodeficiency, and monitoring immune-related conditions. International classification criteria, such as the 2019 EULAR/ACR criteria for systemic lupus erythematosus, incorporate immunologic results alongside clinical findings. These entries describe how such tests are generated and interpreted at a population level and are not a substitute for individualised clinical assessment.
Evidence & guidelines
Test selection and interpretation in this area are shaped by disease-classification criteria and laboratory-practice guidelines from bodies such as EULAR/ACR for rheumatic diseases, the International Union of Immunological Societies for inborn errors of immunity, and national clinical-biochemistry organisations for tumor-marker use. These documents define which analytes are recommended, how they are standardised, and the limits of their interpretation.
History
Clinical immunology testing grew from early twentieth-century serology, through the development of immunofluorescence and radioimmunoassay in the mid-twentieth century, to the modern era of automated immunoassays, flow cytometry, and molecular immunodiagnostics. Successive refinements in assay specificity and standardisation have expanded the menu from a few precipitin reactions to a broad panel of quantitative immune measurements.
Related topics
Seminal works
- ricklin-2010
- tangye-2022
- aringer-2019
Frequently asked questions
- What does immunology and autoimmunity testing measure?
- It measures components and products of the immune system, including autoantibodies, complement proteins, immunoglobulins, immune cell populations, and tumor-associated markers, to help characterise immune function and disease.
- Is a positive autoantibody test enough to diagnose an autoimmune disease?
- No. Immunologic results are interpreted together with clinical findings and, for many conditions, formal classification criteria; a single positive test is not by itself diagnostic.